Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : NTS-105 Prodrug
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : NTS-104 (NTS-105 Prodrug) is a novel, water-soluble neurosteroid prodrug that, when delivered intravenously, is converted in the bloodstream to NTS-105, the active neurosteroid and First-in-Human Dosing for Acute Ischemic Stroke patients.
Product Name : NTS-104
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 06, 2023
Lead Product(s) : NTS-105 Prodrug
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
